1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > OrbusNeich - Product Pipeline Analysis, 2016 Update

OrbusNeich - Product Pipeline Analysis, 2016 Update

  • June 2016
  • -
  • Global Data
  • -
  • 32 pages

Summary

OrbusNeich is a medical device company that designs, develops, manufactures and markets medical devices for cardiovascular markets. It focuses on the development of cardiology devices for the treatment of vascular diseases. The company offers products that include bio-engineered stents, dual therapy stent, bare metal stents and balloons. OrbusNeich’s bio engineered stent is a pro-healing stent that utilizes immobilized antibodies to capture circulating endothelial progenitor cells. The company also conducts several clinical programs. It markets its products through the channel of network distributors. The company has its presence in the Netherlands, China, Japan, Hong Kong, Malaysia and Korea, among others. OrbusNeich is headquartered in Hong Kong.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OrbusNeich
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

OrbusNeich - Product Pipeline Analysis, 2016 Update
Table of Contents
Table of Contents 2


OrbusNeich Company Snapshot 5
OrbusNeich Company Overview 5
OrbusNeich Pipeline Products and Clinical Trials Overview 6
OrbusNeich - Pipeline Analysis Overview 8
Key Facts 8
OrbusNeich - Major Products and Services 9
OrbusNeich Pipeline Products by Development Stage 10
OrbusNeich Clinical Trials by Trial Status 12
OrbusNeich Pipeline Products Overview 14
Acute BRS 14
Acute BRS Product Overview 14
COMBO Dual Therapy Stent 15
COMBO Dual Therapy Stent Product Overview 15
COMBO Dual Therapy Stent Clinical Trial 16
COMBO Dual Therapy Stent - 38 mm 19
COMBO Dual Therapy Stent - 38 mm Product Overview 19
Cura Stent 20
Cura Stent Product Overview 20
ON-AVS Scaffold 21
ON-AVS Scaffold Product Overview 21
OrbusNeich - Key Competitors 22
OrbusNeich - Key Employees 23
OrbusNeich - Locations And Subsidiaries 24
Head Office 24
Other Locations and Subsidiaries 24
Recent Developments 25
OrbusNeich, Recent Developments 25
May 24, 2016: OrbusNeich Expands Portfolio To Include Scoreflex PTA balloon Catheter 25
May 24, 2016: OrbusNeich Introduces News JADE catheter to Treat Peripheral Disease 25
May 03, 2016: OrbusNeich Announces the Last Patient Enrollment in PhysicianInitiated Study to Evaluate the Potential for Shorter Dual Antiplatelet Therapy in ACS Patients 25
Feb 01, 2016: OrbusNeich highlights Sapphire II PRO at AsiaPCR/SingLIVE 2016 26
Feb 01, 2016: OrbusNeich showcases Scoreflex at AsiaPCR/SingLIVE 2016 27
Dec 17, 2015: OrbusNeich demonstrstes Scoreflex Coronary Dilatation Catheter at GulfPCR-GIM 2015 27
Dec 17, 2015: OrbusNeich demonstrates Sapphire II Coronary Dilatation Catheter at GulfPCR-GIM 2015 28
Oct 19, 2015: One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015 29
Jul 20, 2015: OrbusNeich Announces Enrollment of First Patient in China Recovery Study 29
Jun 04, 2015: COMBO Dual Therapy Stent demonstrates true tissue maturation with low clinical events rate out to 4 years at EuroPCR 2015 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
OrbusNeich Pipeline Products and Clinical Trials Overview 6
OrbusNeich Pipeline Products by Equipment Type 6
OrbusNeich Pipeline Products by Indication 7
OrbusNeich Clinical Trials by Trial Status 7
OrbusNeich, Key Facts 8
OrbusNeich, Major Products and Services 9
OrbusNeich Number of Pipeline Products by Development Stage 10
OrbusNeich Pipeline Products Summary by Development Stage 11
OrbusNeich Clinical Trials by Trial Status 12
OrbusNeich Clinical Trials Summary 13
Acute BRS - Product Status 14
Acute BRS - Product Description 14
COMBO Dual Therapy Stent - Product Status 15
COMBO Dual Therapy Stent - Product Description 15
COMBO Dual Therapy Stent - A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients with De Novo Stenotic Lesions of Native Coronary Artery: RECOVERY 16
COMBO Dual Therapy Stent - China Recovery Study of COMBO Dual Therapy Stent 16
COMBO Dual Therapy Stent - Japan-USA Harmonized Assessment by Randomized, Multi-center Study of Orbusneich's Combo Stent (Japan-USA HARMONEE): Assessment of a Novel DES Platform for Percutaneous Coronary Revascularization in Patients with Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome 17
COMBO Dual Therapy Stent - Multicenter, Prospective, Clinical Outcomes after Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio- Engineered Sirolimus Eluting Stent) Post Market Registry 17
COMBO Dual Therapy Stent - Multinational Abluminal Sirolimus Coated Bio-engineered Stent: The MASCOT Post Marketing Registry 18
COMBO Dual Therapy Stent - Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association with Short-term Single Antiplatelet Therapy in Patients with Coronary Artery Disease with an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy 18
COMBO Dual Therapy Stent - 38 mm - Product Status 19
COMBO Dual Therapy Stent - 38 mm - Product Description 19
Cura Stent - Product Status 20
Cura Stent - Product Description 20
ON-AVS Scaffold - Product Status 21
ON-AVS Scaffold - Product Description 21
OrbusNeich, Key Employees 23
OrbusNeich, Other Locations 24
OrbusNeich, Subsidiaries 24

List of Figures
OrbusNeich Pipeline Products by Equipment Type 7
OrbusNeich Pipeline Products by Development Stage 10
OrbusNeich Clinical Trials by Trial Status 12

Companies Mentioned
St. Jude Medical (Hong Kong) Ltd.
Hangzhou Bever Medical Devices Co.,Ltd.
Asia Cardiovascular Products Ltd.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.